chr5-180911545-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001040462.3(BTNL8):āc.604G>Cā(p.Gly202Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,612,680 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001040462.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BTNL8 | NM_001040462.3 | c.604G>C | p.Gly202Arg | missense_variant | 3/8 | ENST00000340184.9 | NP_001035552.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BTNL8 | ENST00000340184.9 | c.604G>C | p.Gly202Arg | missense_variant | 3/8 | 1 | NM_001040462.3 | ENSP00000342197 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000663 AC: 1AN: 150790Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250878Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135570
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461890Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727246
GnomAD4 genome AF: 0.00000663 AC: 1AN: 150790Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73566
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The c.604G>C (p.G202R) alteration is located in exon 3 (coding exon 3) of the BTNL8 gene. This alteration results from a G to C substitution at nucleotide position 604, causing the glycine (G) at amino acid position 202 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at